Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Meyer

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Molecular Cancer|July 5, 2024
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patientsLenka Hovorkova, Lucie Winkowska, Justina Skorepova, et al.
Translational Oncology|March 17, 2019
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic LeukemiaBruno A Lopes, Claus Meyer, Thayana C Barbosa, et al.
Blood|November 4, 2010
High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23)Jenny E Kuipers, Eva A Coenen, Brian V Balgobind, et al.
Blood|September 27, 2023
A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic featuresClara Bueno, Raul Torres-Ruiz, Talia Velasco-Hernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Clinical Implications of Minimal Residual Disease Detection in Infants With <i>KMT2A</i>-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 ProtocolJanine Stutterheim, Inge M van der Sluis, Paola de Lorenzo, et al.
Acta Neuropathologica|March 23, 2011
Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytomaHuriye Cin, Claus Meyer, Ricarda Herr, et al.
Haematologica|October 26, 2010
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemiaBrian V Balgobind, Marry M Van den Heuvel-Eibrink, Renee X De Menezes, et al.
Blood|August 18, 2023
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL studyRathana Kim, Hugo Bergugnat, Cédric Pastoret, et al.
Blood|July 15, 2022
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemiaRicky Tirtakusuma, Katarzyna Szoltysek, Paul Milne, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Molecular Cancer|July 5, 2024
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patientsLenka Hovorkova, Lucie Winkowska, Justina Skorepova, et al.
Translational Oncology|March 17, 2019
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic LeukemiaBruno A Lopes, Claus Meyer, Thayana C Barbosa, et al.
Blood|November 4, 2010
High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23)Jenny E Kuipers, Eva A Coenen, Brian V Balgobind, et al.
Blood|September 27, 2023
A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic featuresClara Bueno, Raul Torres-Ruiz, Talia Velasco-Hernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Clinical Implications of Minimal Residual Disease Detection in Infants With <i>KMT2A</i>-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 ProtocolJanine Stutterheim, Inge M van der Sluis, Paola de Lorenzo, et al.
Acta Neuropathologica|March 23, 2011
Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytomaHuriye Cin, Claus Meyer, Ricarda Herr, et al.
Haematologica|October 26, 2010
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemiaBrian V Balgobind, Marry M Van den Heuvel-Eibrink, Renee X De Menezes, et al.
Blood|August 18, 2023
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL studyRathana Kim, Hugo Bergugnat, Cédric Pastoret, et al.
Blood|July 15, 2022
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemiaRicky Tirtakusuma, Katarzyna Szoltysek, Paul Milne, et al.
Pageof 8